Other signaling pathways, including the COX/COX-2, iNOS/NOS, and MAPK/MAPK pathways, are also confirmed as principal mechanisms through which walnut bioactive compounds improve inflammation in intestinal chronic conditions such as IBD [33,34,38]. This evidence concerns the gene NOS2 and inflammatory bowel disease.